Home Case Index All Cases Central Excise Central Excise + SC Central Excise - 1996 (12) TMI SC This
Forgot password New User/ Regiser ⇒ Register to get Live Demo
1996 (12) TMI 68 - SC - Central ExciseWhether anaesthetics, including Xylocaine, were covered by the definition of a narcotic drug or narcotic in Section 2(h); hence, medicinal preparations containing Xylocaine were assessable to duty under the said Act? Held that - In the present case, it is not enough for the Revenue to state that the said medicinal preparations contain Xylocaine and Xylocaine has the properties mentioned in Section 2(h). What must be set out is what is it that is contained in Xylocaine which contains these properties and, by reason thereof, makes the said medicinal preparations dutiable. As anaesthetics are ingredients of the medicinal preparations sought to be made dutiable. As in the case of Xylocaine, what it is within the anaesthetics that produces drowsiness or sleep or stupefaction or insensibility was not identified. For the reasons aforestated , these appeals must also be dismissed.
Issues:
1. Interpretation of the definition of "narcotic drug" and "narcotic" under the Medicinal and Toilet Preparations (Excise Duties) Act, 1955. 2. Assessment of excise duty on medicinal preparations containing Xylocaine. 3. Determination of dutiability of medicinal preparations containing anaesthetics. 4. Validity of demands issued by the Revenue and their challenge in the High Court. 5. Consideration of whether the State of Gujarat can maintain the appeal. 6. Alleged contravention of Article 14 of the Constitution in relation to the demands on the appellants. Analysis: The Supreme Court of India heard appeals arising from the High Court of Gujarat regarding the assessment of excise duty on medicinal preparations. The main issue revolved around the interpretation of the definition of "narcotic drug" and "narcotic" under the Medicinal and Toilet Preparations (Excise Duties) Act, 1955. The appellants manufactured various medicinal preparations, including anaesthetics like Xylocaine, which were subject to excise duty demands by the Revenue. The High Court, in its judgment, interpreted the Act to require a substance to produce all effects of drowsiness, sleep, stupefaction, and insensibility in order to be classified as a narcotic. However, the Supreme Court disagreed and held that a substance inducing any one of these effects qualifies as a narcotic under the Act. The Court examined the dutiability of medicinal preparations containing Xylocaine and anaesthetics. It emphasized the need for a clear identification of the specific substance within the anaesthetics that produces the required effects to render the preparations dutiable. Merely containing Xylocaine, which itself is a medicinal preparation, was deemed insufficient to justify excise duty imposition. The Court emphasized the necessity of identifying the substance responsible for inducing drowsiness, sleep, stupefaction, or insensibility within the preparations to establish dutiability. Ultimately, the Court upheld the High Court's decision to quash the demands on the appellants, citing the lack of specificity in identifying the dutiable substance within the medicinal preparations. The Court dismissed the appeals, including those concerning anaesthetics as ingredients, due to the absence of clear identification of the substances responsible for the required effects. The Court did not delve into the issues regarding the State of Gujarat's appeal maintenance or the alleged contravention of Article 14 of the Constitution, given the primary conclusion on the dutiability of the medicinal preparations. In conclusion, the Supreme Court's judgment clarified the interpretation of the Act regarding narcotic substances in medicinal preparations and emphasized the necessity of clearly identifying the specific substances responsible for producing the required effects to impose excise duty. The decision provided clarity on the dutiability of medicinal preparations containing anaesthetics and upheld the quashing of demands on the appellants based on the lack of substance-specific identification.
|